Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
about
Current status of biomarkers for prostate cancerA national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancerCurrent early diagnostic biomarkers of prostate cancerOverexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer.Prostate-specific antigen screening in prostate cancer: perspectives on the evidenceCurrent state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from "Challenges and Chances in Prostate Cancer Research Meeting 2013".Transperineal ultrasound-guided 12-core prostate biopsy: an extended approach to diagnose transition zone prostate tumors.Profiling prostate cancer.Prostate-specific antigen screening can be beneficial to younger and at-risk men.Quality of life in men undergoing active surveillance for localized prostate cancer.Knowledge of and Attitudes Toward Evidence-Based Guidelines for and Against Clinical Preventive Services: Results from a National Survey.Consideration of comorbidity in risk stratification prior to prostate biopsy.Risk stratification in prostate cancer screening.Beyond the black box: a systematic review of breast, prostate, colorectal, and cervical screening among native and immigrant African-descent Caribbean populations.Pre-screening age African-American males: what do they know about prostate cancer screening, knowledge, and risk perceptions?Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.Perceptions of prostate cancer fatalism and screening behavior between United States-born and Caribbean-born Black males.Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time.
P2860
Q24600574-A4174665-48E6-4B12-B793-0C1225E32691Q28652628-C786F028-06B7-4E12-81D7-9D30A01C7A21Q33922390-7A07C2BA-E94E-46C8-BA10-5B46C7104FD1Q34129290-4CEE3344-FDFF-43BD-A0C3-31DE35AAFBC8Q34354430-EDA061BD-828A-454F-B1F6-30B40D8BA180Q34528219-D652D2DC-319F-4A66-8192-E363A7520A1AQ35106786-08C2D32B-299B-48DC-8E1A-DAB7C5AEC93FQ35641430-85B0F607-A694-4CED-95C4-9F2AEDE900CBQ36510711-E3F5EA55-568C-4560-B257-D8D37449D5EDQ36520543-29E05F84-C82F-4C3A-B915-DEDB78A95716Q37087876-D8D65E96-D896-49E7-A3F9-ACD6BED7560BQ37415134-925BFDBA-A55B-40A5-8530-E70AF81E6922Q38068114-4CA8A849-5E51-4617-AF7B-28CDADDD9DA9Q38187561-1919FD36-875A-4B41-86C7-2A0224014A4AQ39231745-6761E49A-D968-4BCB-A880-ACFB0165FE76Q41338779-5FBE9E2B-DDBD-43BF-8F34-FEFB3D3442C4Q41873079-B522BFAE-CACC-4D67-B259-EE104512A0F3Q43882657-B4DB1474-A689-4DC6-923E-BCC73353CDC3
P2860
Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
@ast
Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
@en
Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
@nl
type
label
Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
@ast
Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
@en
Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
@nl
prefLabel
Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
@ast
Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
@en
Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
@nl
P356
P1476
Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
@en
P2093
Fritz H Schröder
P304
P356
10.1056/NEJMP1112140
P407
P577
2011-10-26T00:00:00Z